Delivery Order SPE2DB22D1103-SPE2DB25FH0A4
- Not listed
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order on September 9, 2025, by the Defense Logistics Agency (DLA) for the supply of Trulicity 1.5 mg/0.5 ml pen injections valued at $22,414.82. The contract is a firm fixed price delivery order with an ultimate completion date of September 10, 2025, and was awarded without a set-aside designation through competitive procurement. Performance will be executed at...
- AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $1,101.07 by the Defense Logistics Agency (DLA) on July 24, 2025, with an ultimate completion date of July 25, 2025. The contract, utilizing firm fixed pricing with no set-aside designation, calls for the delivery of Trulicity 1.5 mg/0.5 mL pens in 0.5 mL quantities to support federal medical supply needs. This delivery order represents a child contract under AmerisourceBergen's...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a $1,051.05 firm fixed-price delivery order on June 17, 2025, by the Defense Logistics Agency to supply Trulicity 1.5 mg/0.5 ml pens. This delivery order is non-set-aside and represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026. The pharmaceutical...
- AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, received a competitive delivery order award from the Defense Logistics Agency valued at $1,174.94 for Trulicity 0.75 mg/0.5 ml pen medication. The contract carries a firm fixed price structure with an ultimate completion date of July 25, 2025, and was awarded on July 24, 2025. This delivery order represents a child contract executed under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support...
- AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, was awarded a delivery order by the Defense Logistics Agency for Trulicity 1.5 mg/0.5 ml pen (0.5 ml) on September 12, 2025. The contract is valued at $1,201.20 under firm fixed-price terms with an ultimate completion date of September 15, 2025. This delivery order is not set-aside and represents a competitive award issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical,...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $6,006.00 by the Defense Logistics Agency on August 5, 2025, for the supply of Trulicity 0.75 mg/0.5 ml pen injections. The contract, designated as firm fixed price with no set-aside provisions, represents a competitively awarded delivery order executed under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, has been awarded a delivery order by the Defense Logistics Agency (DLA) for Trulicity 1.5 mg/0.5 ml pens with a ceiling value of $3,877.77. The delivery order, issued on September 5, 2025, with an ultimate completion date of September 8, 2025, is structured as a firm fixed price contract with no set-aside designation. This award represents a competitive procurement action under the...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor based in Conshohocken, Pennsylvania, was awarded a delivery order valued at $2,702.70 by the Defense Logistics Agency (DLA) on June 2, 2025, with an ultimate completion date of June 3, 2025. The delivery order is for Trulicity 1.5 mg/0.5 ml pen injectables and was issued under a firm fixed-price, non-set-aside competitive contract. This child delivery order falls under AmerisourceBergen's larger Indefinite Delivery Contract (IDC)...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a $2,717.94 delivery order on August 15, 2025, for the supply of Trulicity 1.5 mg/0.5 ml pen injections, a diabetes medication. This firm fixed-price contract, with an ultimate completion date of August 18, 2025, represents a child delivery order under a larger contract vehicle and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The award was made through open competition with no...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $2,073.89 by the Defense Logistics Agency (DLA) on September 16, 2025, with an ultimate completion date of September 17, 2025. The delivery order, which carries no set-aside designation, is for the supply of Trulicity 3 mg/0.5 mL pens in 0.5 mL quantities under a firm fixed price arrangement. The place of performance is located in Conshohocken,...
- SPE2DB22D1103Indefinite Delivery Contract
- SPE2DB22D1103-SPE2DB25FH0A4Delivery Order
AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, received a delivery order valued at $1,351.35 from the Defense Logistics Agency for Trulicity 1.5 mg/0.5 ml pen (0.5 ml), a diabetes medication. This competitively awarded, firm fixed price delivery order was issued on August 13, 2025, with an ultimate completion date of August 14, 2025. The contract carries no set-aside designation and is performed at the contractor's Conshohocken facility. This delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. As a major pharmaceutical distributor, AmerisourceBergen supplies a comprehensive range of medications and medical supplies to support military healthcare systems and the Defense Health Agency. The company's extensive federal contract portfolio demonstrates its capacity to fulfill diverse pharmaceutical procurement requirements across multiple therapeutic domains through competitive contracting mechanisms.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.4k | 8/13/25 |